The Vermont Attorney General’s Office has been fighting to end the opioid crisis and hold industry accountable for their role in promoting and profiting from the opioid epidemic. As a result of its efforts, both individually and collectively with State Attorneys General, settlements have been reached against the three largest pharmaceutical distributors, McKesson, Cardinal Health and Amerisource Bergen (“Distributors”), and one manufacturer, Janssen Pharmaceuticals, Inc., and its parent company Johnson & Johnson (J&J).
This webpage hosts documents reflecting these settlements including: an executive summary, the settlement agreements with the Distributors and J&J, and supporting exhibits.
- Exhibit E - List of Opioid Remediation Uses
- Exhibit G - Qualified Subdivisions List
- Exhibit K - Subdivision Settlement Participation Form
Following the 2021 settlements with the Distributors and Janssen, settlements were also reached in 2022 with two additional manufacturers-Teva and Allergan- and three pharmacy chains-Walgreens, Walmart, and CVS.
This webpage also hosts information about the 2022 settlements consisting of Opioids Settlement Information for Subdivisions and the settlement agreements. The List of Opioid Remediation Uses in Exhibit E are the same for the settlements with Teva, Allergan, Walgreens, Walmart, and CVS.
Additional information about all Opioids Settlements may be found at https://nationalopioidsettlement.com/